# Crovalimab (Genetical Recombination) Injection 340mg (ピアスカイ注３４０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6399433A1022). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6399433A1022
- **Product name (Japanese):** ピアスカイ注３４０ｍｇ
- **English title:** Crovalimab (Genetical Recombination) Injection 340mg
- **Active ingredient:** クロバリマブ（遺伝子組換え）
- **Active ingredient (INN):** Crovalimab (Genetical Recombination)
- **Strength / unit:** ３４０ｍｇ２ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 63 Biological products (生物学的製剤) › 639 Other biological products (その他の生物学的製剤)
- **Manufacturer:** Chugai Pharmaceutical (中外製薬)
- **NHI price (reference only):** JPY 1978062 per ３４０ｍｇ２ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6399433A1022
- **JSON:** https://www.nifujipharma.com/api/drugs/6399433A1022

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Crovalimab%20(Genetical%20Recombination)%20Injection%20340mg%20(%E3%83%94%E3%82%A2%E3%82%B9%E3%82%AB%E3%82%A4%E6%B3%A8%EF%BC%93%EF%BC%94%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%206399433A1022#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.